Skip to main content

Effect of Depot Medoxyprogesterone Acetate on Immune Functions and Inflammatory Markers of HIV-Infected Women.

Publication ,  Journal Article
Weinberg, A; Park, J-G; Bosch, R; Cho, A; Livingston, E; Aweeka, F; Cramer, Y; Watts, DH; Luque, AE; Cohn, SE
Published in: J Acquir Immune Defic Syndr
February 1, 2016

OBJECTIVES: Depot medroxyprogesterone acetate (DMPA) was associated with increased HIV transmission and accelerated disease progression in untreated women. The potential underlying mechanisms include immune modulation. We evaluated the effect of a single DMPA injection on cell-mediated immunity (CMI), T-cell activation, T-cell regulation (Treg), and inflammation in HIV-infected women on combination antiretroviral regimen (cART). METHODS: Women with HIV plasma RNA ≤ 400 copies per milliliter on stable cART received DMPA and had immunologic and medroxyprogesterone acetate (MPA) measurements at baseline, 4 weeks [peak MPA concentration (Cmax)], and 12 weeks [highest MPA area under the concentration curve]. RESULTS: At baseline, among 24 women with median age of 32 years and 622 CD4(+) cells per microliter, ≥ 68% had HIV, varicella-zoster virus, phytohemagglutinin A and CD3/CD28 CMI measured by lymphocyte proliferation, and/or IFNγ/IL2 dual-color fluorospot. CMI did not significantly change after DMPA administration except for a 1.4-fold increase in IL2/IFNγ varicella-zoster virus fluorospot at week 12. T-cell activation decreased after DMPA administration, reaching statistical significance at week 12 for CD4(+)CD25+%. Treg behaved heterogeneously with an increase in CD8+FOXP3+% at week 4 and a decrease in CD4+IL35+% at week 12. There was a decrease in TGFβ at week 12 and no other changes in plasma biomarkers. Correlation analyses showed that high MPA Cmax and/or area under the concentration curve were significantly associated with increases of IFNγ HIV enzyme-linked ImmunoSpot, CD4+IL35+%, and CD4+TGFβ+% Treg and decreases of plasma IL10 from baseline to weeks 4 and/or 12. CONCLUSIONS: A single dose of DMPA did not have immune-suppressive or pro-inflammatory effects in HIV-infected women on cART. Additional studies need to assess the effect of multiple doses.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Acquir Immune Defic Syndr

DOI

EISSN

1944-7884

Publication Date

February 1, 2016

Volume

71

Issue

2

Start / End Page

137 / 145

Location

United States

Related Subject Headings

  • Young Adult
  • Virology
  • T-Lymphocytes, Regulatory
  • Middle Aged
  • Medroxyprogesterone Acetate
  • Lymphocyte Activation
  • Injections, Intramuscular
  • Inflammation
  • Immunity, Cellular
  • Humans
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Weinberg, A., Park, J.-G., Bosch, R., Cho, A., Livingston, E., Aweeka, F., … Cohn, S. E. (2016). Effect of Depot Medoxyprogesterone Acetate on Immune Functions and Inflammatory Markers of HIV-Infected Women. J Acquir Immune Defic Syndr, 71(2), 137–145. https://doi.org/10.1097/QAI.0000000000000850
Weinberg, Adriana, Jeong-Gun Park, Ronald Bosch, Alice Cho, Elizabeth Livingston, Fran Aweeka, Yoninah Cramer, D Heather Watts, Amneris E. Luque, and Susan E. Cohn. “Effect of Depot Medoxyprogesterone Acetate on Immune Functions and Inflammatory Markers of HIV-Infected Women.J Acquir Immune Defic Syndr 71, no. 2 (February 1, 2016): 137–45. https://doi.org/10.1097/QAI.0000000000000850.
Weinberg A, Park J-G, Bosch R, Cho A, Livingston E, Aweeka F, et al. Effect of Depot Medoxyprogesterone Acetate on Immune Functions and Inflammatory Markers of HIV-Infected Women. J Acquir Immune Defic Syndr. 2016 Feb 1;71(2):137–45.
Weinberg, Adriana, et al. “Effect of Depot Medoxyprogesterone Acetate on Immune Functions and Inflammatory Markers of HIV-Infected Women.J Acquir Immune Defic Syndr, vol. 71, no. 2, Feb. 2016, pp. 137–45. Pubmed, doi:10.1097/QAI.0000000000000850.
Weinberg A, Park J-G, Bosch R, Cho A, Livingston E, Aweeka F, Cramer Y, Watts DH, Luque AE, Cohn SE. Effect of Depot Medoxyprogesterone Acetate on Immune Functions and Inflammatory Markers of HIV-Infected Women. J Acquir Immune Defic Syndr. 2016 Feb 1;71(2):137–145.

Published In

J Acquir Immune Defic Syndr

DOI

EISSN

1944-7884

Publication Date

February 1, 2016

Volume

71

Issue

2

Start / End Page

137 / 145

Location

United States

Related Subject Headings

  • Young Adult
  • Virology
  • T-Lymphocytes, Regulatory
  • Middle Aged
  • Medroxyprogesterone Acetate
  • Lymphocyte Activation
  • Injections, Intramuscular
  • Inflammation
  • Immunity, Cellular
  • Humans